Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2008
11/06/2008WO2007126765A3 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
11/06/2008WO2007106721A3 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/06/2008US20080275245 Processes for the Preparation of Substituted Sulfoxides
11/06/2008US20080275242 3-(Dihydro(Tetrahydro)Isoquinolin-1-Yl)Quinoline Compound
11/06/2008US20080275238 4-(Hydroxyalkyl-)-piperazinyl(thio)acetamide derivatives for treatment of cardiovascular disorders; antiarrhythmia agents; intermittent claudication, angina, congestive heart failure and myocardial infarction; diabetes
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275092 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/06/2008US20080275090 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/06/2008US20080275088 Use of Collismycin and Derivatives Thereof as Oxidative Stress Inhibitors
11/06/2008US20080275086 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes
11/06/2008US20080275085 Piperidine derivative and use thereof
11/06/2008US20080275084 CCR3 or H1; autoimmune, inflammatory, proliferative diseases, immunologically-mediated diseases (including rejection of transplanted organs or tissues AIDS); Ethyl 2-(4-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}piperidin-1-yl)cyclohexanecarboxylate; reacting ethyl 2-amino-1-cyclohexane carboxylate
11/06/2008US20080275083 2,3,4,9-tetrahydro-1h-carbazoles
11/06/2008US20080275070 Aryl Ether Compounds and Their Preparation and Use Thereof
11/06/2008US20080275069 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
11/06/2008US20080275065 insecticide for representatives of the order Acarina; protection of plant propagation material from the attack by pests; N-(4-chloro-2-methyl-6-[([oxetan-2-ylmethyl]amino)carbonyl]phenyl)-1-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
11/06/2008US20080275062 Benzamide rho-kinase (ROCK-1) inhibitors; N-benzyl-4-(4-pyridinyl)benzamide
11/06/2008US20080275061 Method for controlling particular insect pests by applying anthranilamide compounds
11/06/2008US20080275058 N-Substituted-1H-Quinoline-2,4-Diones, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same
11/06/2008US20080275057 Cell cycle G2-checkpoint-abrogating 1-[(2-pyridyl)amino]-azoline-2,5-dione derivatives with at least one halogen group, to selectively sensitize cancer cells to DNA damaging reagents without additional anticarcinogenic treatment; cytolytic agents, antiproliferatives, apoptosis
11/06/2008US20080275056 Pyrazole-Isoquinoline Urea Derivatives as P38 Kinase Inhibitors
11/06/2008US20080275053 Heterocyclyl Compounds
11/06/2008US20080275046 1-(3-{4-[4-(piperidin-1-ylmethyl)-1,3-oxazol-2-yl]phenoxy}propyl)piperidine; 4,4-difluoro-1-[(4-methyl-2-{4-[3-(2-methylpyrrolidin-1-yl)propoxy]phenyl}-1,3-thiazol-5-yl)carbonyl]piperidine; histamine H3-receptor antagonists; Parkinson's and Alzheimer's diseases; sleep disorders; antiepileptics
11/06/2008US20080275045 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
11/06/2008US20080275044 Vanilloid receptor 1 antagonists; reducing a phenyl or 3-pyridyl carboxylic acid or ester to an alcohol, aziding, reduction to a primary amine, amidation with a (3-fluoro-4-methylsulfonamido)phenyl acetic acid; 2-(3-Fluoro-4-(methylsulfonamido)phenyl)-N-(substituted phenyl or pyrid-3-yl) acetamides
11/06/2008US20080275043 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1
11/06/2008US20080275041 3-[5-({4-[2-(Dipropylamino)ethyl]piperazin-1-yl}sulfonyl)pyridin-2-yl]-2-hydroxy-1H-indole-6-carbonitrile hydrochloride; Alzheimer's Disease, Parkinson's Disease, depression, schizophrenia, HIV, Down syndrome, bone disorders, alopecia
11/06/2008US20080275040 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders
11/06/2008US20080275032 Pyridazinone compounds
11/06/2008US20080275031 Inhibitors of C-FMS Kinase
11/06/2008US20080275029 Compounds for Treating Protein-Kinase Mediated Disorders
11/06/2008US20080275028 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
11/06/2008US20080275027 Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists
11/06/2008US20080275025 Substituted Lactams and Their Use as Anti-Cancer Agents
11/06/2008US20080275024 Amyloid precursor protein/gamma-secretase inhibitors; amides of aminobenzodiazepines: 2-(3,5-difluorophenyl)-N {[N-(1-methyl-2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))carbamoyl]cyclohexyl}acetamide
11/06/2008US20080275022 Substituted Quinazolones as Anti-Cancer Agents
11/06/2008US20080275004 N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/06/2008US20080274983 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases
11/06/2008US20080274891 Pyridine-3-ketone compound; plant growth controllers
11/06/2008US20080274517 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
11/06/2008US20080274107 Tyrosine kinase inhibitors
11/06/2008US20080274082 Oximyl hydroxyamic analogs as hepatitis c virus protease inhibitor
11/06/2008CA2756791A1 Trpv1 antagonists and uses thereof
11/06/2008CA2687943A1 N'-(phenyl)-n-(morpholin-4-yl-pyridin-2-yl)-pyrimidine-2,4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions
11/06/2008CA2685567A1 Pyridonecarboxamides, crop protection agents containing the same, method for production and use thereof
11/06/2008CA2685529A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/06/2008CA2685266A1 Trpv1 antagonists and uses thereof for the treatment of prevention of pain, ui and ulcer, ibd, or ibs in an animal
11/06/2008CA2685121A1 Therapeutic agents useful for treating pain
11/06/2008CA2683866A1 Bridged six-membered ring compounds
11/06/2008CA2683159A1 Isoquinolinone derivatives as nk3 antagonists
11/06/2008CA2682508A1 Dual-acting antihypertensive agents
11/06/2008CA2682032A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/05/2008EP1988089A1 Imatinib base, and imatinib mesylate and processes for preparation thereof
11/05/2008EP1988078A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1988076A1 Amide derivative or salt thereof
11/05/2008EP1988075A1 Pyrrole derivative or salt thereof
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1987717A1 Pyridon carboxamides, agents containing these but not impacting useful plants and method for their manufacture and application
11/05/2008EP1987023A1 Hydrate forms of amg706
11/05/2008EP1987022A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives
11/05/2008EP1987021A1 Substituted prolinamides, their preparation and their use as pharmaceuticals
11/05/2008EP1987020A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1987019A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators
11/05/2008EP1987009A1 Cyclourea compounds as calcium channel blockers
11/05/2008EP1987007A1 3-aminopyrazolines for treatment of neurodegenerative and psychiatric diseases
11/05/2008EP1987006A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1987003A1 Pyridine-2-carboxamide derivatives
11/05/2008EP1987000A2 Diaryl piperidines as cb1 modulators
11/05/2008EP1986998A1 Metabotropic glutamate receptor-potentiating soindolones
11/05/2008EP1986747A2 Quinolones useful as inducible nitric oxide synthase inhibitors
11/05/2008EP1986659A2 Stable dosage formulations of imidazolylalkyl-pyridines
11/05/2008EP1824844B1 Pyrazine dicarboxamides and the use thereof
11/05/2008EP1761515B1 2-(hetero-)aryl substituted tetrahydroquinoline derivatives
11/05/2008EP1713781B1 Quinazoline derivatives
11/05/2008EP1709028B1 Fused heteroaryl derivatives and their use as p38 kinase inhibitors
11/05/2008EP1638969B1 Cgrp receptor antagonists
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008EP1505945B1 Substituted cycloalkyl p1' hepatitis c virus inhibitors
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008EP1296973B1 Guanidine derivatives of quinazoline for use in the treatment of autoimmune diseases
11/05/2008EP1053227B1 Ppar-gamma modulators
11/05/2008CN101300250A Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
11/05/2008CN101300249A Aminoquinoline and aminoquinazoline kinase modulators
11/05/2008CN101300248A Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections
11/05/2008CN101300236A Triazole compounds as lipoxygenase inhibitors
11/05/2008CN101300235A Diaminopyrimidines as P2X3 and P2X2/3 modulators
11/05/2008CN101300233A Azafused cyclin dependent kinase inhibitors
11/05/2008CN101300230A N-(hetero) aryl indole derivatives as pesticides
11/05/2008CN101300229A 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
11/05/2008CN101298451A Benzamide compounds and use thereof
11/05/2008CN101298435A O-formammidotiazol-benzamide compounds and use thereof
11/05/2008CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
11/05/2008CN100430394C Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
11/05/2008CN100430386C Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/05/2008CN100430383C Benzimidazoles that are useful in treating sexual dysfunction
11/05/2008CN100430378C New piperidine derivative
11/05/2008CN100430059C Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
11/05/2008CN100430058C Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
1 ... 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 ... 1080